RSB Spine, LLC, Announces European Patent Allowance

CLEVELAND, Nov. 15, 2011 /PRNewswire/ -- RSB Spine, LLC, today announced allowance of  European Patent 1847240 covering specific design iterations of its line of InterPlate® cervical and lumbar intervertebral fusion devices.

"Fusion remains one of the most common spinal procedures performed by neurosurgeons and orthopedic surgeons, despite the introduction of numerous disc replacement implants," commented James M. Moran, D. Eng., the company's chief technical officer. "This intellectual property reinforces RSB's freedom to respond to evolving surgeon preferences and supports our plans for European sales. Ongoing legal disputes also highlight the need for medical device companies to have the protection of a strong patent portfolio."

In July, the company received a United States Patent involving design of interbody devices that prevent stress shielding, complementing a previous European approval for the same concepts.

RSB Spine is a privately held medical device company. News releases and other information on the company are available on the Internet at: www.rsbspine.com and www.paradigmbiodevices.com.

SOURCE RSB Spine, LLC